Every Spin-Off
Mandi Inc.
AnnouncedHKSells Mandi-brand minoxidil hair-loss treatments to consumers in China, mainly through online stores and pharmacies.
Mandi, 3SBio's consumer hair-loss treatment business (minoxidil brand Mandi), is being spun off for a separate listing on the Main Board of HKEX.
- Status
- Announced
- Expected
- Timing not announced
- Parent
- 3SBio (1530 HK)
- Spin-off ticker
- To be announced
- Listing
- Main Board of HKEX
- Market
- Hong Kong
- Sector
- Health care
Terms
Global offering combined with a conditional special dividend paid out of share premium by distribution in specie of all Mandi shares held by 3SBio (about 87.16% of Mandi), pro rata to qualifying shareholders, after which 3SBio keeps no interest; EGM to approve the distribution was convened for 23 April 2026; ratio and record date to be set by the board and conditional on the offering and listing; not listed as of late September 2026.
Key dates
- Spin-off proposal and listing application
- Board declares conditional distribution in specie
- Circular
- EGM
- Record date and listing
Source documents
- Press releaseConditional special dividend by distribution in specie (03/30/26)
- PresentationNot yet published
- Prospectus / demerger documentNot yet public
- Sourcehkexnews.hk (board meeting notice 03/17/26)
- Sourcejingdaily.com
- Sourcehkexnews.hk (proposed spin-off 11/20/25)
- Sourceitiger.com (EGM notice 04/01/26)
- Sourcestock.10jqka.com.cn (09/22/26)
Every Spin-Off research
No report on this situation yet. New reports are published on Substack first.
Receive reports by email